context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
Certain derivative actions were brought against the officers named in the Securities Class Action, and certain current and former directors of the Company, alleging claims relating to the matters at issue in the Securities Class Action. In February 2024, formal stipulations of settlement incorporating the substantive terms of the memoranda of understanding and detailing the proposed settlements’ operational terms were submitted for court approval. The orders approving the formal stipulations of settlement became final and non-appealable in the second and third quarters of 2024, respectively, and the Company fulfilled all of its obligations pursuant to such stipulations of settlements . The settlements are without any admission of the allegations in the complaints, which the defendants deny. In the second quarter of 2024, the Company’s insurers funded $ 2.8 million to an escrow account established for the purpose of paying the settlement amounts in accordance with the terms of the applicable settlement, and the Company reversed the previously recorded $ 2.8 million legal reserve within accrued expenses and other liabilities and the related $ 2.8 million receivable within other assets on the Consolidated Balance Sheets. | text | 2.8 | monetaryItemType | text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> Certain derivative actions were brought against the officers named in the Securities Class Action, and certain current and former directors of the Company, alleging claims relating to the matters at issue in the Securities Class Action. In February 2024, formal stipulations of settlement incorporating the substantive terms of the memoranda of understanding and detailing the proposed settlements’ operational terms were submitted for court approval. The orders approving the formal stipulations of settlement became final and non-appealable in the second and third quarters of 2024, respectively, and the Company fulfilled all of its obligations pursuant to such stipulations of settlements . The settlements are without any admission of the allegations in the complaints, which the defendants deny. In the second quarter of 2024, the Company’s insurers funded $ 2.8 million to an escrow account established for the purpose of paying the settlement amounts in accordance with the terms of the applicable settlement, and the Company reversed the previously recorded $ 2.8 million legal reserve within accrued expenses and other liabilities and the related $ 2.8 million receivable within other assets on the Consolidated Balance Sheets. </context> | us-gaap:ProceedsFromInsuranceSettlementOperatingActivities |
Certain derivative actions were brought against the officers named in the Securities Class Action, and certain current and former directors of the Company, alleging claims relating to the matters at issue in the Securities Class Action. In February 2024, formal stipulations of settlement incorporating the substantive terms of the memoranda of understanding and detailing the proposed settlements’ operational terms were submitted for court approval. The orders approving the formal stipulations of settlement became final and non-appealable in the second and third quarters of 2024, respectively, and the Company fulfilled all of its obligations pursuant to such stipulations of settlements . The settlements are without any admission of the allegations in the complaints, which the defendants deny. In the second quarter of 2024, the Company’s insurers funded $ 2.8 million to an escrow account established for the purpose of paying the settlement amounts in accordance with the terms of the applicable settlement, and the Company reversed the previously recorded $ 2.8 million legal reserve within accrued expenses and other liabilities and the related $ 2.8 million receivable within other assets on the Consolidated Balance Sheets. | text | 2.8 | monetaryItemType | text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> Certain derivative actions were brought against the officers named in the Securities Class Action, and certain current and former directors of the Company, alleging claims relating to the matters at issue in the Securities Class Action. In February 2024, formal stipulations of settlement incorporating the substantive terms of the memoranda of understanding and detailing the proposed settlements’ operational terms were submitted for court approval. The orders approving the formal stipulations of settlement became final and non-appealable in the second and third quarters of 2024, respectively, and the Company fulfilled all of its obligations pursuant to such stipulations of settlements . The settlements are without any admission of the allegations in the complaints, which the defendants deny. In the second quarter of 2024, the Company’s insurers funded $ 2.8 million to an escrow account established for the purpose of paying the settlement amounts in accordance with the terms of the applicable settlement, and the Company reversed the previously recorded $ 2.8 million legal reserve within accrued expenses and other liabilities and the related $ 2.8 million receivable within other assets on the Consolidated Balance Sheets. </context> | us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease |
Certain derivative actions were brought against the officers named in the Securities Class Action, and certain current and former directors of the Company, alleging claims relating to the matters at issue in the Securities Class Action. In February 2024, formal stipulations of settlement incorporating the substantive terms of the memoranda of understanding and detailing the proposed settlements’ operational terms were submitted for court approval. The orders approving the formal stipulations of settlement became final and non-appealable in the second and third quarters of 2024, respectively, and the Company fulfilled all of its obligations pursuant to such stipulations of settlements . The settlements are without any admission of the allegations in the complaints, which the defendants deny. In the second quarter of 2024, the Company’s insurers funded $ 2.8 million to an escrow account established for the purpose of paying the settlement amounts in accordance with the terms of the applicable settlement, and the Company reversed the previously recorded $ 2.8 million legal reserve within accrued expenses and other liabilities and the related $ 2.8 million receivable within other assets on the Consolidated Balance Sheets. | text | 2.8 | monetaryItemType | text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> Certain derivative actions were brought against the officers named in the Securities Class Action, and certain current and former directors of the Company, alleging claims relating to the matters at issue in the Securities Class Action. In February 2024, formal stipulations of settlement incorporating the substantive terms of the memoranda of understanding and detailing the proposed settlements’ operational terms were submitted for court approval. The orders approving the formal stipulations of settlement became final and non-appealable in the second and third quarters of 2024, respectively, and the Company fulfilled all of its obligations pursuant to such stipulations of settlements . The settlements are without any admission of the allegations in the complaints, which the defendants deny. In the second quarter of 2024, the Company’s insurers funded $ 2.8 million to an escrow account established for the purpose of paying the settlement amounts in accordance with the terms of the applicable settlement, and the Company reversed the previously recorded $ 2.8 million legal reserve within accrued expenses and other liabilities and the related $ 2.8 million receivable within other assets on the Consolidated Balance Sheets. </context> | us-gaap:IncreaseDecreaseInInsuranceSettlementsReceivable |
In connection with certain facility transitions, we have agreed to indemnify certain operators in certain events. As of December 31, 2024, our maximum funding commitment under these indemnification agreements was approximately $ 11.4 million. Claims under these indemnification agreements generally may be made within 18 months to 72 months of the transition date. These indemnification agreements were provided to certain operators in connection with facility transitions and generally would be applicable if the prior operators do not perform under their transition agreements. | text | 11.4 | monetaryItemType | text: <entity> 11.4 </entity> <entity type> monetaryItemType </entity type> <context> In connection with certain facility transitions, we have agreed to indemnify certain operators in certain events. As of December 31, 2024, our maximum funding commitment under these indemnification agreements was approximately $ 11.4 million. Claims under these indemnification agreements generally may be made within 18 months to 72 months of the transition date. These indemnification agreements were provided to certain operators in connection with facility transitions and generally would be applicable if the prior operators do not perform under their transition agreements. </context> | us-gaap:OtherCommitment |
During the third quarter of 2024, we amended the existing master lease with Brookdale Senior Living Inc. (“Brookdale”) to extend the maturity date from December 2027 to December 2037. As part of the amendment, we agreed to provide up to $ 80.0 million in funding for capital expenditures on the facilities subject to the master lease (included in the table above). The annual rent under the lease will not be adjusted for fundings of capital expenditures in the aggregate amount of up to $ 30.0 million of the $ 80.0 million commitment. With respect to the remaining $ 50.0 million of the $ 80.0 million commitment, the annual rent under the lease will increase by the amount of each capital expenditure multiplied by 9.5 %. | text | 80.0 | monetaryItemType | text: <entity> 80.0 </entity> <entity type> monetaryItemType </entity type> <context> During the third quarter of 2024, we amended the existing master lease with Brookdale Senior Living Inc. (“Brookdale”) to extend the maturity date from December 2027 to December 2037. As part of the amendment, we agreed to provide up to $ 80.0 million in funding for capital expenditures on the facilities subject to the master lease (included in the table above). The annual rent under the lease will not be adjusted for fundings of capital expenditures in the aggregate amount of up to $ 30.0 million of the $ 80.0 million commitment. With respect to the remaining $ 50.0 million of the $ 80.0 million commitment, the annual rent under the lease will increase by the amount of each capital expenditure multiplied by 9.5 %. </context> | us-gaap:ContractualObligation |
During the third quarter of 2024, we amended the existing master lease with Brookdale Senior Living Inc. (“Brookdale”) to extend the maturity date from December 2027 to December 2037. As part of the amendment, we agreed to provide up to $ 80.0 million in funding for capital expenditures on the facilities subject to the master lease (included in the table above). The annual rent under the lease will not be adjusted for fundings of capital expenditures in the aggregate amount of up to $ 30.0 million of the $ 80.0 million commitment. With respect to the remaining $ 50.0 million of the $ 80.0 million commitment, the annual rent under the lease will increase by the amount of each capital expenditure multiplied by 9.5 %. | text | 30.0 | monetaryItemType | text: <entity> 30.0 </entity> <entity type> monetaryItemType </entity type> <context> During the third quarter of 2024, we amended the existing master lease with Brookdale Senior Living Inc. (“Brookdale”) to extend the maturity date from December 2027 to December 2037. As part of the amendment, we agreed to provide up to $ 80.0 million in funding for capital expenditures on the facilities subject to the master lease (included in the table above). The annual rent under the lease will not be adjusted for fundings of capital expenditures in the aggregate amount of up to $ 30.0 million of the $ 80.0 million commitment. With respect to the remaining $ 50.0 million of the $ 80.0 million commitment, the annual rent under the lease will increase by the amount of each capital expenditure multiplied by 9.5 %. </context> | us-gaap:ContractualObligation |
During the third quarter of 2024, we amended the existing master lease with Brookdale Senior Living Inc. (“Brookdale”) to extend the maturity date from December 2027 to December 2037. As part of the amendment, we agreed to provide up to $ 80.0 million in funding for capital expenditures on the facilities subject to the master lease (included in the table above). The annual rent under the lease will not be adjusted for fundings of capital expenditures in the aggregate amount of up to $ 30.0 million of the $ 80.0 million commitment. With respect to the remaining $ 50.0 million of the $ 80.0 million commitment, the annual rent under the lease will increase by the amount of each capital expenditure multiplied by 9.5 %. | text | 50.0 | monetaryItemType | text: <entity> 50.0 </entity> <entity type> monetaryItemType </entity type> <context> During the third quarter of 2024, we amended the existing master lease with Brookdale Senior Living Inc. (“Brookdale”) to extend the maturity date from December 2027 to December 2037. As part of the amendment, we agreed to provide up to $ 80.0 million in funding for capital expenditures on the facilities subject to the master lease (included in the table above). The annual rent under the lease will not be adjusted for fundings of capital expenditures in the aggregate amount of up to $ 30.0 million of the $ 80.0 million commitment. With respect to the remaining $ 50.0 million of the $ 80.0 million commitment, the annual rent under the lease will increase by the amount of each capital expenditure multiplied by 9.5 %. </context> | us-gaap:ContractualObligation |
We conduct our operations and report financial results as one business segment. The presentation of financial results as one reportable segment is consistent with the way we operate our business and is consistent with the manner in which our CODM, our Chief Executive Officer, evaluates performance and makes resource and operating decisions for the business. | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> We conduct our operations and report financial results as one business segment. The presentation of financial results as one reportable segment is consistent with the way we operate our business and is consistent with the manner in which our CODM, our Chief Executive Officer, evaluates performance and makes resource and operating decisions for the business. </context> | us-gaap:NumberOfOperatingSegments |
We conduct our operations and report financial results as one business segment. The presentation of financial results as one reportable segment is consistent with the way we operate our business and is consistent with the manner in which our CODM, our Chief Executive Officer, evaluates performance and makes resource and operating decisions for the business. | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> We conduct our operations and report financial results as one business segment. The presentation of financial results as one reportable segment is consistent with the way we operate our business and is consistent with the manner in which our CODM, our Chief Executive Officer, evaluates performance and makes resource and operating decisions for the business. </context> | us-gaap:NumberOfReportableSegments |
We account for our stock-based awards in accordance with provisions of ASC 718, Compensation – Stock Compensation which includes guidance for accounting for a modification of existing stock-based compensation awards. In connection with the transition discussed above and the modification of certain of Mr. Booth’s equity awards, the Company will incur non-cash stock-based compensation expense of $ 6.6 million in the first quarter of 2025. | text | 6.6 | monetaryItemType | text: <entity> 6.6 </entity> <entity type> monetaryItemType </entity type> <context> We account for our stock-based awards in accordance with provisions of ASC 718, Compensation – Stock Compensation which includes guidance for accounting for a modification of existing stock-based compensation awards. In connection with the transition discussed above and the modification of certain of Mr. Booth’s equity awards, the Company will incur non-cash stock-based compensation expense of $ 6.6 million in the first quarter of 2025. </context> | us-gaap:ShareBasedCompensation |
In January 2025, we funded a $ 15.4 million mortgage loan to one operator. The loan bears interest at 11.0 % and matures in June 2030 . | text | 15.4 | monetaryItemType | text: <entity> 15.4 </entity> <entity type> monetaryItemType </entity type> <context> In January 2025, we funded a $ 15.4 million mortgage loan to one operator. The loan bears interest at 11.0 % and matures in June 2030 . </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
In January 2025, we funded a $ 15.4 million mortgage loan to one operator. The loan bears interest at 11.0 % and matures in June 2030 . | text | 11.0 | percentItemType | text: <entity> 11.0 </entity> <entity type> percentItemType </entity type> <context> In January 2025, we funded a $ 15.4 million mortgage loan to one operator. The loan bears interest at 11.0 % and matures in June 2030 . </context> | us-gaap:InvestmentInterestRate |
In January 2025, we acquired two facilities in Texas for consideration of $ 10.6 million and leased them to one new operator. The facilities have an initial annual cash yield of 9.9 % with annual escalators of 2.0 %. | text | two | integerItemType | text: <entity> two </entity> <entity type> integerItemType </entity type> <context> In January 2025, we acquired two facilities in Texas for consideration of $ 10.6 million and leased them to one new operator. The facilities have an initial annual cash yield of 9.9 % with annual escalators of 2.0 %. </context> | us-gaap:NumberOfRealEstateProperties |
In January 2025, we acquired two facilities in Texas for consideration of $ 10.6 million and leased them to one new operator. The facilities have an initial annual cash yield of 9.9 % with annual escalators of 2.0 %. | text | 10.6 | monetaryItemType | text: <entity> 10.6 </entity> <entity type> monetaryItemType </entity type> <context> In January 2025, we acquired two facilities in Texas for consideration of $ 10.6 million and leased them to one new operator. The facilities have an initial annual cash yield of 9.9 % with annual escalators of 2.0 %. </context> | us-gaap:PaymentsToAcquireRealEstate |
Net of the total remeasurement, including both the impact of assumption changes and the effect of actual to expected experience adjustments, resulting in gains (losses) of $ 29.4 million, $( 47.4 ) million and $( 11.1 ) million for the year ended December 31, 2023, 2022 and 2021, respectively. | text | 29.4 | monetaryItemType | text: <entity> 29.4 </entity> <entity type> monetaryItemType </entity type> <context> Net of the total remeasurement, including both the impact of assumption changes and the effect of actual to expected experience adjustments, resulting in gains (losses) of $ 29.4 million, $( 47.4 ) million and $( 11.1 ) million for the year ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:LiabilityForFuturePolicyBenefitRemeasurementGainLoss |
Net of the total remeasurement, including both the impact of assumption changes and the effect of actual to expected experience adjustments, resulting in gains (losses) of $ 29.4 million, $( 47.4 ) million and $( 11.1 ) million for the year ended December 31, 2023, 2022 and 2021, respectively. | text | 47.4 | monetaryItemType | text: <entity> 47.4 </entity> <entity type> monetaryItemType </entity type> <context> Net of the total remeasurement, including both the impact of assumption changes and the effect of actual to expected experience adjustments, resulting in gains (losses) of $ 29.4 million, $( 47.4 ) million and $( 11.1 ) million for the year ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:LiabilityForFuturePolicyBenefitRemeasurementGainLoss |
Net of the total remeasurement, including both the impact of assumption changes and the effect of actual to expected experience adjustments, resulting in gains (losses) of $ 29.4 million, $( 47.4 ) million and $( 11.1 ) million for the year ended December 31, 2023, 2022 and 2021, respectively. | text | 11.1 | monetaryItemType | text: <entity> 11.1 </entity> <entity type> monetaryItemType </entity type> <context> Net of the total remeasurement, including both the impact of assumption changes and the effect of actual to expected experience adjustments, resulting in gains (losses) of $ 29.4 million, $( 47.4 ) million and $( 11.1 ) million for the year ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:LiabilityForFuturePolicyBenefitRemeasurementGainLoss |
Net of the total remeasurement, including both the impact of assumption changes and the effect of actual to expected experience adjustments, resulting in gains (losses) of $ 11.8 million, $ 15.6 million and $( 1.2 ) million for the year ended December 31, 2023, 2022 and 2021, respectively. | text | 11.8 | monetaryItemType | text: <entity> 11.8 </entity> <entity type> monetaryItemType </entity type> <context> Net of the total remeasurement, including both the impact of assumption changes and the effect of actual to expected experience adjustments, resulting in gains (losses) of $ 11.8 million, $ 15.6 million and $( 1.2 ) million for the year ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:LiabilityForFuturePolicyBenefitRemeasurementGainLoss |
Net of the total remeasurement, including both the impact of assumption changes and the effect of actual to expected experience adjustments, resulting in gains (losses) of $ 11.8 million, $ 15.6 million and $( 1.2 ) million for the year ended December 31, 2023, 2022 and 2021, respectively. | text | 15.6 | monetaryItemType | text: <entity> 15.6 </entity> <entity type> monetaryItemType </entity type> <context> Net of the total remeasurement, including both the impact of assumption changes and the effect of actual to expected experience adjustments, resulting in gains (losses) of $ 11.8 million, $ 15.6 million and $( 1.2 ) million for the year ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:LiabilityForFuturePolicyBenefitRemeasurementGainLoss |
Net of the total remeasurement, including both the impact of assumption changes and the effect of actual to expected experience adjustments, resulting in gains (losses) of $ 11.8 million, $ 15.6 million and $( 1.2 ) million for the year ended December 31, 2023, 2022 and 2021, respectively. | text | 1.2 | monetaryItemType | text: <entity> 1.2 </entity> <entity type> monetaryItemType </entity type> <context> Net of the total remeasurement, including both the impact of assumption changes and the effect of actual to expected experience adjustments, resulting in gains (losses) of $ 11.8 million, $ 15.6 million and $( 1.2 ) million for the year ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:LiabilityForFuturePolicyBenefitRemeasurementGainLoss |
Globe Life provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The Company is organized into four reportable segments: life insurance, supplemental health insurance, annuities, and investments. | text | four | integerItemType | text: <entity> four </entity> <entity type> integerItemType </entity type> <context> Globe Life provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The Company is organized into four reportable segments: life insurance, supplemental health insurance, annuities, and investments. </context> | us-gaap:NumberOfReportableSegments |
On August 1, 2021, the Company acquired Beazley Benefits, an operating unit of Beazley Insurance Company, Inc. for $ 59.2 million. In conjunction with this agreement, the Company also executed a 100% coinsurance agreement assuming the remaining inforce business produced by the unit. The acquisition was accounted for under the acquisition method of accounting as required by GAAP. This guidance requires the assets acquired and liabilities assumed be based on their fair values at the acquisition date. The goodwill related to the purchase is due to expected synergies as a result of combining operations with other factors. The results of operations since the acquisition date have been consolidated. The cash flows associated with the purchase are recorded in the | text | 59.2 | monetaryItemType | text: <entity> 59.2 </entity> <entity type> monetaryItemType </entity type> <context> On August 1, 2021, the Company acquired Beazley Benefits, an operating unit of Beazley Insurance Company, Inc. for $ 59.2 million. In conjunction with this agreement, the Company also executed a 100% coinsurance agreement assuming the remaining inforce business produced by the unit. The acquisition was accounted for under the acquisition method of accounting as required by GAAP. This guidance requires the assets acquired and liabilities assumed be based on their fair values at the acquisition date. The goodwill related to the purchase is due to expected synergies as a result of combining operations with other factors. The results of operations since the acquisition date have been consolidated. The cash flows associated with the purchase are recorded in the </context> | us-gaap:BusinessCombinationConsiderationTransferred1 |
"Mortgage loans" or commercial mortgage loans, are a type of investment where the mortgage loan is shared among investors, are accounted for as financing receivables. The commercial mortgage loans are managed by a third party. The Company purchased the legal rights to interests in commercial mortgage loans which are secured by properties such as hotels, retail, multiple family, or offices. The commercial mortgage loans typically have a term of 3 years with the option to extend up to 2 years. The commercial mortgage loans are recorded at unpaid principal balance, net of unamortized origination fees and net of allowance for loan losses. Interest income, net of the amortization of origination fees, is recorded in "Net investment income" under the effective yield method. Our unfunded commitment balance to the commercial loan borrowers was $ 25 million as of December 31, 2023. | text | 25 | monetaryItemType | text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> "Mortgage loans" or commercial mortgage loans, are a type of investment where the mortgage loan is shared among investors, are accounted for as financing receivables. The commercial mortgage loans are managed by a third party. The Company purchased the legal rights to interests in commercial mortgage loans which are secured by properties such as hotels, retail, multiple family, or offices. The commercial mortgage loans typically have a term of 3 years with the option to extend up to 2 years. The commercial mortgage loans are recorded at unpaid principal balance, net of unamortized origination fees and net of allowance for loan losses. Interest income, net of the amortization of origination fees, is recorded in "Net investment income" under the effective yield method. Our unfunded commitment balance to the commercial loan borrowers was $ 25 million as of December 31, 2023. </context> | us-gaap:NotesReceivableNet |
The investment funds consist of limited partnerships whereby the Company has a pro-rata share of ownership ranging from less than 1 % to 20 %. For each investment, the Company has elected the fair value option, but would have been otherwise accounted for as an equity method investment. The fair value option is assessed for each individual investment and concluded at the inception of the investment. | text | 1 | percentItemType | text: <entity> 1 </entity> <entity type> percentItemType </entity type> <context> The investment funds consist of limited partnerships whereby the Company has a pro-rata share of ownership ranging from less than 1 % to 20 %. For each investment, the Company has elected the fair value option, but would have been otherwise accounted for as an equity method investment. The fair value option is assessed for each individual investment and concluded at the inception of the investment. </context> | us-gaap:VariableInterestEntityOwnershipPercentage |
The investment funds consist of limited partnerships whereby the Company has a pro-rata share of ownership ranging from less than 1 % to 20 %. For each investment, the Company has elected the fair value option, but would have been otherwise accounted for as an equity method investment. The fair value option is assessed for each individual investment and concluded at the inception of the investment. | text | 20 | percentItemType | text: <entity> 20 </entity> <entity type> percentItemType </entity type> <context> The investment funds consist of limited partnerships whereby the Company has a pro-rata share of ownership ranging from less than 1 % to 20 %. For each investment, the Company has elected the fair value option, but would have been otherwise accounted for as an equity method investment. The fair value option is assessed for each individual investment and concluded at the inception of the investment. </context> | us-gaap:VariableInterestEntityOwnershipPercentage |
Each limited partnership investment is evaluated under applicable GAAP to determine if it is a variable interest entity (VIE) and would qualify for consolidation. Only primary beneficiaries are required or allowed to consolidate VIEs. The investments are not consolidated because the Company has no power to control the activities that most significantly affect the economic performance of these entities and therefore the Company is not the primary beneficiary of any of these interests. Globe Life's involvement is limited to its limited partnership interest in the entities. The Company has not provided any other financial support to the entities beyond its commitments to fund its limited partnership interests, and there are no arrangements or agreements with any of the interests to provide other financial support. The maximum loss exposure relative to these interests is limited to their carrying value and future commitments. The Company has approximately 2 % of total assets in low-income housing tax credits and certain limited partnerships (investment funds) that qualify as unconsolidated VIEs. | text | 2 | percentItemType | text: <entity> 2 </entity> <entity type> percentItemType </entity type> <context> Each limited partnership investment is evaluated under applicable GAAP to determine if it is a variable interest entity (VIE) and would qualify for consolidation. Only primary beneficiaries are required or allowed to consolidate VIEs. The investments are not consolidated because the Company has no power to control the activities that most significantly affect the economic performance of these entities and therefore the Company is not the primary beneficiary of any of these interests. Globe Life's involvement is limited to its limited partnership interest in the entities. The Company has not provided any other financial support to the entities beyond its commitments to fund its limited partnership interests, and there are no arrangements or agreements with any of the interests to provide other financial support. The maximum loss exposure relative to these interests is limited to their carrying value and future commitments. The Company has approximately 2 % of total assets in low-income housing tax credits and certain limited partnerships (investment funds) that qualify as unconsolidated VIEs. </context> | us-gaap:ConcentrationRiskPercentage1 |
The limited partnership investments are reported at the Company's pro-rata share of the investment fund's net asset value or its equivalent (NAV), as a practical expedient for fair value. Changes in the NAV are recorded in net income and increase the carrying value on the balance sheet. The amount of change in NAV attributable to the net operating results of the fund is recorded in "Net investment income" with the remaining balance of the change reflected in "Realized gains (losses)." Distributions received from the funds reduce the carrying value. Our maximum exposure to loss is equal to the outstanding carrying value and future funding commitments. The Company had $ 154 million of capital called during the year from existing investment funds, reducing our unfunded commitments. Our unfunded commitments were $ 744 million as of December 31, 2023. | text | 154 | monetaryItemType | text: <entity> 154 </entity> <entity type> monetaryItemType </entity type> <context> The limited partnership investments are reported at the Company's pro-rata share of the investment fund's net asset value or its equivalent (NAV), as a practical expedient for fair value. Changes in the NAV are recorded in net income and increase the carrying value on the balance sheet. The amount of change in NAV attributable to the net operating results of the fund is recorded in "Net investment income" with the remaining balance of the change reflected in "Realized gains (losses)." Distributions received from the funds reduce the carrying value. Our maximum exposure to loss is equal to the outstanding carrying value and future funding commitments. The Company had $ 154 million of capital called during the year from existing investment funds, reducing our unfunded commitments. Our unfunded commitments were $ 744 million as of December 31, 2023. </context> | us-gaap:PaymentsToAcquireLongtermInvestments |
The limited partnership investments are reported at the Company's pro-rata share of the investment fund's net asset value or its equivalent (NAV), as a practical expedient for fair value. Changes in the NAV are recorded in net income and increase the carrying value on the balance sheet. The amount of change in NAV attributable to the net operating results of the fund is recorded in "Net investment income" with the remaining balance of the change reflected in "Realized gains (losses)." Distributions received from the funds reduce the carrying value. Our maximum exposure to loss is equal to the outstanding carrying value and future funding commitments. The Company had $ 154 million of capital called during the year from existing investment funds, reducing our unfunded commitments. Our unfunded commitments were $ 744 million as of December 31, 2023. | text | 744 | monetaryItemType | text: <entity> 744 </entity> <entity type> monetaryItemType </entity type> <context> The limited partnership investments are reported at the Company's pro-rata share of the investment fund's net asset value or its equivalent (NAV), as a practical expedient for fair value. Changes in the NAV are recorded in net income and increase the carrying value on the balance sheet. The amount of change in NAV attributable to the net operating results of the fund is recorded in "Net investment income" with the remaining balance of the change reflected in "Realized gains (losses)." Distributions received from the funds reduce the carrying value. Our maximum exposure to loss is equal to the outstanding carrying value and future funding commitments. The Company had $ 154 million of capital called during the year from existing investment funds, reducing our unfunded commitments. Our unfunded commitments were $ 744 million as of December 31, 2023. </context> | us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments |
" Accrued investment income " also consists of interest income earned on the commercial mortgage loan portfolio, but which is yet to be received as of the balance sheet date. Accrued investment income will be placed in non-accrual status at the time the loan is 90 days delinquent or otherwise deemed to be uncollectible by management. Any currently accrued investment income will subsequently be written off. As of December 31, 2023, the accrued interest receivable for commercial mortgage loans was $ 1.7 million. Mortgage loans generally pay interest monthly, therefore accrued interest is typically for a period of less than 30 days. | text | 1.7 | monetaryItemType | text: <entity> 1.7 </entity> <entity type> monetaryItemType </entity type> <context> " Accrued investment income " also consists of interest income earned on the commercial mortgage loan portfolio, but which is yet to be received as of the balance sheet date. Accrued investment income will be placed in non-accrual status at the time the loan is 90 days delinquent or otherwise deemed to be uncollectible by management. Any currently accrued investment income will subsequently be written off. As of December 31, 2023, the accrued interest receivable for commercial mortgage loans was $ 1.7 million. Mortgage loans generally pay interest monthly, therefore accrued interest is typically for a period of less than 30 days. </context> | us-gaap:FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss |
: Costs related to advertising are generally charged to expense as incurred. However, certain Direct to Consumer advertising costs are capitalized when there is a reliable and demonstrated relationship between total costs and future benefits that is a direct result of incurring these costs. Direct to Consumer advertising costs consist primarily of internet advertising costs and the production and distribution costs of direct mail advertising materials, and when capitalized are included as a component of DAC. Additionally, they are amortized in the same manner as other DAC. Direct to Consumer advertising costs charged to earnings and included in commissions, premium taxes, and non-deferred acquisition costs were $ 19.2 million, $ 9.4 million, and $ 10.0 million in 2023, 2022, and 2021, respectively. Unamortized capitalized advertising costs included within DAC were $ 1.6 billion at December 31, 2023 and $ 1.5 billion at December 31, 2022. | text | 1.6 | monetaryItemType | text: <entity> 1.6 </entity> <entity type> monetaryItemType </entity type> <context> : Costs related to advertising are generally charged to expense as incurred. However, certain Direct to Consumer advertising costs are capitalized when there is a reliable and demonstrated relationship between total costs and future benefits that is a direct result of incurring these costs. Direct to Consumer advertising costs consist primarily of internet advertising costs and the production and distribution costs of direct mail advertising materials, and when capitalized are included as a component of DAC. Additionally, they are amortized in the same manner as other DAC. Direct to Consumer advertising costs charged to earnings and included in commissions, premium taxes, and non-deferred acquisition costs were $ 19.2 million, $ 9.4 million, and $ 10.0 million in 2023, 2022, and 2021, respectively. Unamortized capitalized advertising costs included within DAC were $ 1.6 billion at December 31, 2023 and $ 1.5 billion at December 31, 2022. </context> | us-gaap:CapitalizedContractCostNet |
: Costs related to advertising are generally charged to expense as incurred. However, certain Direct to Consumer advertising costs are capitalized when there is a reliable and demonstrated relationship between total costs and future benefits that is a direct result of incurring these costs. Direct to Consumer advertising costs consist primarily of internet advertising costs and the production and distribution costs of direct mail advertising materials, and when capitalized are included as a component of DAC. Additionally, they are amortized in the same manner as other DAC. Direct to Consumer advertising costs charged to earnings and included in commissions, premium taxes, and non-deferred acquisition costs were $ 19.2 million, $ 9.4 million, and $ 10.0 million in 2023, 2022, and 2021, respectively. Unamortized capitalized advertising costs included within DAC were $ 1.6 billion at December 31, 2023 and $ 1.5 billion at December 31, 2022. | text | 1.5 | monetaryItemType | text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> : Costs related to advertising are generally charged to expense as incurred. However, certain Direct to Consumer advertising costs are capitalized when there is a reliable and demonstrated relationship between total costs and future benefits that is a direct result of incurring these costs. Direct to Consumer advertising costs consist primarily of internet advertising costs and the production and distribution costs of direct mail advertising materials, and when capitalized are included as a component of DAC. Additionally, they are amortized in the same manner as other DAC. Direct to Consumer advertising costs charged to earnings and included in commissions, premium taxes, and non-deferred acquisition costs were $ 19.2 million, $ 9.4 million, and $ 10.0 million in 2023, 2022, and 2021, respectively. Unamortized capitalized advertising costs included within DAC were $ 1.6 billion at December 31, 2023 and $ 1.5 billion at December 31, 2022. </context> | us-gaap:CapitalizedContractCostNet |
Property and equipment, included in “Other assets,” is reported at cost less accumulated depreciation. Depreciation is recorded primarily on the straight line method over the estimated useful lives of these assets which range from three to fifteen years for equipment and software, and fifteen to forty years for buildings and improvements. Ordinary maintenance and repairs are charged to income as incurred. Impairments, if any, are recorded when certain events and circumstances become evident that the fair value of the asset is less than its carrying amount. Original cost of property and equipment was $ 455 million at December 31, 2023 and $ 406 million at December 31, 2022. Accumulated depreciation was $ 215 million at the end of 2023 and $ 194 million at the end of 2022. Depreciation expense was $ 21 million in 2023, $ 21 million in 2022, and $ 20 million in 2021. Internally generated software costs are expensed as incurred in the preliminary project phase and post-implementation phase, and are capitalized during the application development stage. Additionally, implementation costs incurred in a hosting arrangement that is a service contract are capitalized. See below for a breakout of the net balance by asset class for the year-ended December 31, 2023 and 2022: | text | 455 | monetaryItemType | text: <entity> 455 </entity> <entity type> monetaryItemType </entity type> <context> Property and equipment, included in “Other assets,” is reported at cost less accumulated depreciation. Depreciation is recorded primarily on the straight line method over the estimated useful lives of these assets which range from three to fifteen years for equipment and software, and fifteen to forty years for buildings and improvements. Ordinary maintenance and repairs are charged to income as incurred. Impairments, if any, are recorded when certain events and circumstances become evident that the fair value of the asset is less than its carrying amount. Original cost of property and equipment was $ 455 million at December 31, 2023 and $ 406 million at December 31, 2022. Accumulated depreciation was $ 215 million at the end of 2023 and $ 194 million at the end of 2022. Depreciation expense was $ 21 million in 2023, $ 21 million in 2022, and $ 20 million in 2021. Internally generated software costs are expensed as incurred in the preliminary project phase and post-implementation phase, and are capitalized during the application development stage. Additionally, implementation costs incurred in a hosting arrangement that is a service contract are capitalized. See below for a breakout of the net balance by asset class for the year-ended December 31, 2023 and 2022: </context> | us-gaap:PropertyPlantAndEquipmentGross |
Property and equipment, included in “Other assets,” is reported at cost less accumulated depreciation. Depreciation is recorded primarily on the straight line method over the estimated useful lives of these assets which range from three to fifteen years for equipment and software, and fifteen to forty years for buildings and improvements. Ordinary maintenance and repairs are charged to income as incurred. Impairments, if any, are recorded when certain events and circumstances become evident that the fair value of the asset is less than its carrying amount. Original cost of property and equipment was $ 455 million at December 31, 2023 and $ 406 million at December 31, 2022. Accumulated depreciation was $ 215 million at the end of 2023 and $ 194 million at the end of 2022. Depreciation expense was $ 21 million in 2023, $ 21 million in 2022, and $ 20 million in 2021. Internally generated software costs are expensed as incurred in the preliminary project phase and post-implementation phase, and are capitalized during the application development stage. Additionally, implementation costs incurred in a hosting arrangement that is a service contract are capitalized. See below for a breakout of the net balance by asset class for the year-ended December 31, 2023 and 2022: | text | 406 | monetaryItemType | text: <entity> 406 </entity> <entity type> monetaryItemType </entity type> <context> Property and equipment, included in “Other assets,” is reported at cost less accumulated depreciation. Depreciation is recorded primarily on the straight line method over the estimated useful lives of these assets which range from three to fifteen years for equipment and software, and fifteen to forty years for buildings and improvements. Ordinary maintenance and repairs are charged to income as incurred. Impairments, if any, are recorded when certain events and circumstances become evident that the fair value of the asset is less than its carrying amount. Original cost of property and equipment was $ 455 million at December 31, 2023 and $ 406 million at December 31, 2022. Accumulated depreciation was $ 215 million at the end of 2023 and $ 194 million at the end of 2022. Depreciation expense was $ 21 million in 2023, $ 21 million in 2022, and $ 20 million in 2021. Internally generated software costs are expensed as incurred in the preliminary project phase and post-implementation phase, and are capitalized during the application development stage. Additionally, implementation costs incurred in a hosting arrangement that is a service contract are capitalized. See below for a breakout of the net balance by asset class for the year-ended December 31, 2023 and 2022: </context> | us-gaap:PropertyPlantAndEquipmentGross |
Property and equipment, included in “Other assets,” is reported at cost less accumulated depreciation. Depreciation is recorded primarily on the straight line method over the estimated useful lives of these assets which range from three to fifteen years for equipment and software, and fifteen to forty years for buildings and improvements. Ordinary maintenance and repairs are charged to income as incurred. Impairments, if any, are recorded when certain events and circumstances become evident that the fair value of the asset is less than its carrying amount. Original cost of property and equipment was $ 455 million at December 31, 2023 and $ 406 million at December 31, 2022. Accumulated depreciation was $ 215 million at the end of 2023 and $ 194 million at the end of 2022. Depreciation expense was $ 21 million in 2023, $ 21 million in 2022, and $ 20 million in 2021. Internally generated software costs are expensed as incurred in the preliminary project phase and post-implementation phase, and are capitalized during the application development stage. Additionally, implementation costs incurred in a hosting arrangement that is a service contract are capitalized. See below for a breakout of the net balance by asset class for the year-ended December 31, 2023 and 2022: | text | 215 | monetaryItemType | text: <entity> 215 </entity> <entity type> monetaryItemType </entity type> <context> Property and equipment, included in “Other assets,” is reported at cost less accumulated depreciation. Depreciation is recorded primarily on the straight line method over the estimated useful lives of these assets which range from three to fifteen years for equipment and software, and fifteen to forty years for buildings and improvements. Ordinary maintenance and repairs are charged to income as incurred. Impairments, if any, are recorded when certain events and circumstances become evident that the fair value of the asset is less than its carrying amount. Original cost of property and equipment was $ 455 million at December 31, 2023 and $ 406 million at December 31, 2022. Accumulated depreciation was $ 215 million at the end of 2023 and $ 194 million at the end of 2022. Depreciation expense was $ 21 million in 2023, $ 21 million in 2022, and $ 20 million in 2021. Internally generated software costs are expensed as incurred in the preliminary project phase and post-implementation phase, and are capitalized during the application development stage. Additionally, implementation costs incurred in a hosting arrangement that is a service contract are capitalized. See below for a breakout of the net balance by asset class for the year-ended December 31, 2023 and 2022: </context> | us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment |
Property and equipment, included in “Other assets,” is reported at cost less accumulated depreciation. Depreciation is recorded primarily on the straight line method over the estimated useful lives of these assets which range from three to fifteen years for equipment and software, and fifteen to forty years for buildings and improvements. Ordinary maintenance and repairs are charged to income as incurred. Impairments, if any, are recorded when certain events and circumstances become evident that the fair value of the asset is less than its carrying amount. Original cost of property and equipment was $ 455 million at December 31, 2023 and $ 406 million at December 31, 2022. Accumulated depreciation was $ 215 million at the end of 2023 and $ 194 million at the end of 2022. Depreciation expense was $ 21 million in 2023, $ 21 million in 2022, and $ 20 million in 2021. Internally generated software costs are expensed as incurred in the preliminary project phase and post-implementation phase, and are capitalized during the application development stage. Additionally, implementation costs incurred in a hosting arrangement that is a service contract are capitalized. See below for a breakout of the net balance by asset class for the year-ended December 31, 2023 and 2022: | text | 194 | monetaryItemType | text: <entity> 194 </entity> <entity type> monetaryItemType </entity type> <context> Property and equipment, included in “Other assets,” is reported at cost less accumulated depreciation. Depreciation is recorded primarily on the straight line method over the estimated useful lives of these assets which range from three to fifteen years for equipment and software, and fifteen to forty years for buildings and improvements. Ordinary maintenance and repairs are charged to income as incurred. Impairments, if any, are recorded when certain events and circumstances become evident that the fair value of the asset is less than its carrying amount. Original cost of property and equipment was $ 455 million at December 31, 2023 and $ 406 million at December 31, 2022. Accumulated depreciation was $ 215 million at the end of 2023 and $ 194 million at the end of 2022. Depreciation expense was $ 21 million in 2023, $ 21 million in 2022, and $ 20 million in 2021. Internally generated software costs are expensed as incurred in the preliminary project phase and post-implementation phase, and are capitalized during the application development stage. Additionally, implementation costs incurred in a hosting arrangement that is a service contract are capitalized. See below for a breakout of the net balance by asset class for the year-ended December 31, 2023 and 2022: </context> | us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment |
Property and equipment, included in “Other assets,” is reported at cost less accumulated depreciation. Depreciation is recorded primarily on the straight line method over the estimated useful lives of these assets which range from three to fifteen years for equipment and software, and fifteen to forty years for buildings and improvements. Ordinary maintenance and repairs are charged to income as incurred. Impairments, if any, are recorded when certain events and circumstances become evident that the fair value of the asset is less than its carrying amount. Original cost of property and equipment was $ 455 million at December 31, 2023 and $ 406 million at December 31, 2022. Accumulated depreciation was $ 215 million at the end of 2023 and $ 194 million at the end of 2022. Depreciation expense was $ 21 million in 2023, $ 21 million in 2022, and $ 20 million in 2021. Internally generated software costs are expensed as incurred in the preliminary project phase and post-implementation phase, and are capitalized during the application development stage. Additionally, implementation costs incurred in a hosting arrangement that is a service contract are capitalized. See below for a breakout of the net balance by asset class for the year-ended December 31, 2023 and 2022: | text | 21 | monetaryItemType | text: <entity> 21 </entity> <entity type> monetaryItemType </entity type> <context> Property and equipment, included in “Other assets,” is reported at cost less accumulated depreciation. Depreciation is recorded primarily on the straight line method over the estimated useful lives of these assets which range from three to fifteen years for equipment and software, and fifteen to forty years for buildings and improvements. Ordinary maintenance and repairs are charged to income as incurred. Impairments, if any, are recorded when certain events and circumstances become evident that the fair value of the asset is less than its carrying amount. Original cost of property and equipment was $ 455 million at December 31, 2023 and $ 406 million at December 31, 2022. Accumulated depreciation was $ 215 million at the end of 2023 and $ 194 million at the end of 2022. Depreciation expense was $ 21 million in 2023, $ 21 million in 2022, and $ 20 million in 2021. Internally generated software costs are expensed as incurred in the preliminary project phase and post-implementation phase, and are capitalized during the application development stage. Additionally, implementation costs incurred in a hosting arrangement that is a service contract are capitalized. See below for a breakout of the net balance by asset class for the year-ended December 31, 2023 and 2022: </context> | us-gaap:Depreciation |
Property and equipment, included in “Other assets,” is reported at cost less accumulated depreciation. Depreciation is recorded primarily on the straight line method over the estimated useful lives of these assets which range from three to fifteen years for equipment and software, and fifteen to forty years for buildings and improvements. Ordinary maintenance and repairs are charged to income as incurred. Impairments, if any, are recorded when certain events and circumstances become evident that the fair value of the asset is less than its carrying amount. Original cost of property and equipment was $ 455 million at December 31, 2023 and $ 406 million at December 31, 2022. Accumulated depreciation was $ 215 million at the end of 2023 and $ 194 million at the end of 2022. Depreciation expense was $ 21 million in 2023, $ 21 million in 2022, and $ 20 million in 2021. Internally generated software costs are expensed as incurred in the preliminary project phase and post-implementation phase, and are capitalized during the application development stage. Additionally, implementation costs incurred in a hosting arrangement that is a service contract are capitalized. See below for a breakout of the net balance by asset class for the year-ended December 31, 2023 and 2022: | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> Property and equipment, included in “Other assets,” is reported at cost less accumulated depreciation. Depreciation is recorded primarily on the straight line method over the estimated useful lives of these assets which range from three to fifteen years for equipment and software, and fifteen to forty years for buildings and improvements. Ordinary maintenance and repairs are charged to income as incurred. Impairments, if any, are recorded when certain events and circumstances become evident that the fair value of the asset is less than its carrying amount. Original cost of property and equipment was $ 455 million at December 31, 2023 and $ 406 million at December 31, 2022. Accumulated depreciation was $ 215 million at the end of 2023 and $ 194 million at the end of 2022. Depreciation expense was $ 21 million in 2023, $ 21 million in 2022, and $ 20 million in 2021. Internally generated software costs are expensed as incurred in the preliminary project phase and post-implementation phase, and are capitalized during the application development stage. Additionally, implementation costs incurred in a hosting arrangement that is a service contract are capitalized. See below for a breakout of the net balance by asset class for the year-ended December 31, 2023 and 2022: </context> | us-gaap:Depreciation |
Premium income for traditional long-duration life and health insurance products is recognized evenly over the contract period and when due from the policyholder. Premiums for short-duration health contracts are recognized as revenue over the contract period in proportion to the insurance protection provided. Premiums for universal life-type and annuity contracts are added to the policy account value, and revenues for such products are recognized as charges to the policy account value for mortality, administration, and surrenders (retrospective deposit method). Life premium includes policy charges of $ 12.9 million, $ 13.5 million, and $ 14.2 million for the years ended December 31, 2023, 2022, and 2021, respectively. Other premium consists of annuity policy charges in each year. For most insurance products, the related benefits and expenses are matched with revenues by means of the provision of future policy benefits and the amortization of DAC in a manner which recognizes profits as they are earned over the revenue recognition period. For limited-payment life insurance products, the profits are recognized over the contract period. | text | 12.9 | monetaryItemType | text: <entity> 12.9 </entity> <entity type> monetaryItemType </entity type> <context> Premium income for traditional long-duration life and health insurance products is recognized evenly over the contract period and when due from the policyholder. Premiums for short-duration health contracts are recognized as revenue over the contract period in proportion to the insurance protection provided. Premiums for universal life-type and annuity contracts are added to the policy account value, and revenues for such products are recognized as charges to the policy account value for mortality, administration, and surrenders (retrospective deposit method). Life premium includes policy charges of $ 12.9 million, $ 13.5 million, and $ 14.2 million for the years ended December 31, 2023, 2022, and 2021, respectively. Other premium consists of annuity policy charges in each year. For most insurance products, the related benefits and expenses are matched with revenues by means of the provision of future policy benefits and the amortization of DAC in a manner which recognizes profits as they are earned over the revenue recognition period. For limited-payment life insurance products, the profits are recognized over the contract period. </context> | us-gaap:InsuranceCommissionsAndFees |
Premium income for traditional long-duration life and health insurance products is recognized evenly over the contract period and when due from the policyholder. Premiums for short-duration health contracts are recognized as revenue over the contract period in proportion to the insurance protection provided. Premiums for universal life-type and annuity contracts are added to the policy account value, and revenues for such products are recognized as charges to the policy account value for mortality, administration, and surrenders (retrospective deposit method). Life premium includes policy charges of $ 12.9 million, $ 13.5 million, and $ 14.2 million for the years ended December 31, 2023, 2022, and 2021, respectively. Other premium consists of annuity policy charges in each year. For most insurance products, the related benefits and expenses are matched with revenues by means of the provision of future policy benefits and the amortization of DAC in a manner which recognizes profits as they are earned over the revenue recognition period. For limited-payment life insurance products, the profits are recognized over the contract period. | text | 13.5 | monetaryItemType | text: <entity> 13.5 </entity> <entity type> monetaryItemType </entity type> <context> Premium income for traditional long-duration life and health insurance products is recognized evenly over the contract period and when due from the policyholder. Premiums for short-duration health contracts are recognized as revenue over the contract period in proportion to the insurance protection provided. Premiums for universal life-type and annuity contracts are added to the policy account value, and revenues for such products are recognized as charges to the policy account value for mortality, administration, and surrenders (retrospective deposit method). Life premium includes policy charges of $ 12.9 million, $ 13.5 million, and $ 14.2 million for the years ended December 31, 2023, 2022, and 2021, respectively. Other premium consists of annuity policy charges in each year. For most insurance products, the related benefits and expenses are matched with revenues by means of the provision of future policy benefits and the amortization of DAC in a manner which recognizes profits as they are earned over the revenue recognition period. For limited-payment life insurance products, the profits are recognized over the contract period. </context> | us-gaap:InsuranceCommissionsAndFees |
Premium income for traditional long-duration life and health insurance products is recognized evenly over the contract period and when due from the policyholder. Premiums for short-duration health contracts are recognized as revenue over the contract period in proportion to the insurance protection provided. Premiums for universal life-type and annuity contracts are added to the policy account value, and revenues for such products are recognized as charges to the policy account value for mortality, administration, and surrenders (retrospective deposit method). Life premium includes policy charges of $ 12.9 million, $ 13.5 million, and $ 14.2 million for the years ended December 31, 2023, 2022, and 2021, respectively. Other premium consists of annuity policy charges in each year. For most insurance products, the related benefits and expenses are matched with revenues by means of the provision of future policy benefits and the amortization of DAC in a manner which recognizes profits as they are earned over the revenue recognition period. For limited-payment life insurance products, the profits are recognized over the contract period. | text | 14.2 | monetaryItemType | text: <entity> 14.2 </entity> <entity type> monetaryItemType </entity type> <context> Premium income for traditional long-duration life and health insurance products is recognized evenly over the contract period and when due from the policyholder. Premiums for short-duration health contracts are recognized as revenue over the contract period in proportion to the insurance protection provided. Premiums for universal life-type and annuity contracts are added to the policy account value, and revenues for such products are recognized as charges to the policy account value for mortality, administration, and surrenders (retrospective deposit method). Life premium includes policy charges of $ 12.9 million, $ 13.5 million, and $ 14.2 million for the years ended December 31, 2023, 2022, and 2021, respectively. Other premium consists of annuity policy charges in each year. For most insurance products, the related benefits and expenses are matched with revenues by means of the provision of future policy benefits and the amortization of DAC in a manner which recognizes profits as they are earned over the revenue recognition period. For limited-payment life insurance products, the profits are recognized over the contract period. </context> | us-gaap:InsuranceCommissionsAndFees |
The Company previously accounted for certain group Medicare supplement policies with termination clauses as long-duration contracts. The termination clause precludes the insurance policies from being guaranteed renewable contracts and accordingly should be accounted for as short-duration contracts. In connection with the adoption of ASU 2018-12, the Company changed this accounting, with corresponding adjustments to DAC, future policy benefits, and retained earnings, resulting in an increase of $ 26.5 million, net of tax, to the opening retained earnings balance as of January 1, 2021. | text | 26.5 | monetaryItemType | text: <entity> 26.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company previously accounted for certain group Medicare supplement policies with termination clauses as long-duration contracts. The termination clause precludes the insurance policies from being guaranteed renewable contracts and accordingly should be accounted for as short-duration contracts. In connection with the adoption of ASU 2018-12, the Company changed this accounting, with corresponding adjustments to DAC, future policy benefits, and retained earnings, resulting in an increase of $ 26.5 million, net of tax, to the opening retained earnings balance as of January 1, 2021. </context> | us-gaap:StockholdersEquity |
The Company also previously presented reinsurance recoverable on a net basis as a component of policy liabilities. In the fourth quarter of 2023, the Company corrected its presentation for reinsurance recoverable to a gross basis as a component of other assets, which resulted in the reclassification of $ 59.7 million, $ 82.4 million, and $ 49.9 million of reinsurance recoverable from liabilities to assets as of December 31, 2022, 2021, and 2020, respectively. | text | 59.7 | monetaryItemType | text: <entity> 59.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company also previously presented reinsurance recoverable on a net basis as a component of policy liabilities. In the fourth quarter of 2023, the Company corrected its presentation for reinsurance recoverable to a gross basis as a component of other assets, which resulted in the reclassification of $ 59.7 million, $ 82.4 million, and $ 49.9 million of reinsurance recoverable from liabilities to assets as of December 31, 2022, 2021, and 2020, respectively. </context> | us-gaap:ReinsuranceRecoverables |
The Company also previously presented reinsurance recoverable on a net basis as a component of policy liabilities. In the fourth quarter of 2023, the Company corrected its presentation for reinsurance recoverable to a gross basis as a component of other assets, which resulted in the reclassification of $ 59.7 million, $ 82.4 million, and $ 49.9 million of reinsurance recoverable from liabilities to assets as of December 31, 2022, 2021, and 2020, respectively. | text | 82.4 | monetaryItemType | text: <entity> 82.4 </entity> <entity type> monetaryItemType </entity type> <context> The Company also previously presented reinsurance recoverable on a net basis as a component of policy liabilities. In the fourth quarter of 2023, the Company corrected its presentation for reinsurance recoverable to a gross basis as a component of other assets, which resulted in the reclassification of $ 59.7 million, $ 82.4 million, and $ 49.9 million of reinsurance recoverable from liabilities to assets as of December 31, 2022, 2021, and 2020, respectively. </context> | us-gaap:ReinsuranceRecoverables |
The Company also previously presented reinsurance recoverable on a net basis as a component of policy liabilities. In the fourth quarter of 2023, the Company corrected its presentation for reinsurance recoverable to a gross basis as a component of other assets, which resulted in the reclassification of $ 59.7 million, $ 82.4 million, and $ 49.9 million of reinsurance recoverable from liabilities to assets as of December 31, 2022, 2021, and 2020, respectively. | text | 49.9 | monetaryItemType | text: <entity> 49.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company also previously presented reinsurance recoverable on a net basis as a component of policy liabilities. In the fourth quarter of 2023, the Company corrected its presentation for reinsurance recoverable to a gross basis as a component of other assets, which resulted in the reclassification of $ 59.7 million, $ 82.4 million, and $ 49.9 million of reinsurance recoverable from liabilities to assets as of December 31, 2022, 2021, and 2020, respectively. </context> | us-gaap:ReinsuranceRecoverables |
The Company has exposure to banks within our fixed maturity portfolio, with an average credit rating of A- . The Company’s bank securities had a fair value of $ 1.3 billion ( 7 % of the total fixed maturity portfolio) and $ 1.3 billion ( 8 % of the total fixed maturity portfolio) at December 31, 2023 and December 31, 2022, respectively. Additionally, the Company has exposure to real estate investment trusts with an average rating of BBB+, which had a fair value of $ 425 million ( 2 % of the total fixed maturity portfolio) and $ 428 million ( 3 % of the total fixed maturity portfolio) at December 31, 2023 and December 31, 2022, respectively. | text | 1.3 | monetaryItemType | text: <entity> 1.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company has exposure to banks within our fixed maturity portfolio, with an average credit rating of A- . The Company’s bank securities had a fair value of $ 1.3 billion ( 7 % of the total fixed maturity portfolio) and $ 1.3 billion ( 8 % of the total fixed maturity portfolio) at December 31, 2023 and December 31, 2022, respectively. Additionally, the Company has exposure to real estate investment trusts with an average rating of BBB+, which had a fair value of $ 425 million ( 2 % of the total fixed maturity portfolio) and $ 428 million ( 3 % of the total fixed maturity portfolio) at December 31, 2023 and December 31, 2022, respectively. </context> | us-gaap:AvailableForSaleSecuritiesDebtSecurities |
The Company has exposure to banks within our fixed maturity portfolio, with an average credit rating of A- . The Company’s bank securities had a fair value of $ 1.3 billion ( 7 % of the total fixed maturity portfolio) and $ 1.3 billion ( 8 % of the total fixed maturity portfolio) at December 31, 2023 and December 31, 2022, respectively. Additionally, the Company has exposure to real estate investment trusts with an average rating of BBB+, which had a fair value of $ 425 million ( 2 % of the total fixed maturity portfolio) and $ 428 million ( 3 % of the total fixed maturity portfolio) at December 31, 2023 and December 31, 2022, respectively. | text | 425 | monetaryItemType | text: <entity> 425 </entity> <entity type> monetaryItemType </entity type> <context> The Company has exposure to banks within our fixed maturity portfolio, with an average credit rating of A- . The Company’s bank securities had a fair value of $ 1.3 billion ( 7 % of the total fixed maturity portfolio) and $ 1.3 billion ( 8 % of the total fixed maturity portfolio) at December 31, 2023 and December 31, 2022, respectively. Additionally, the Company has exposure to real estate investment trusts with an average rating of BBB+, which had a fair value of $ 425 million ( 2 % of the total fixed maturity portfolio) and $ 428 million ( 3 % of the total fixed maturity portfolio) at December 31, 2023 and December 31, 2022, respectively. </context> | us-gaap:AvailableForSaleSecuritiesDebtSecurities |
The Company has exposure to banks within our fixed maturity portfolio, with an average credit rating of A- . The Company’s bank securities had a fair value of $ 1.3 billion ( 7 % of the total fixed maturity portfolio) and $ 1.3 billion ( 8 % of the total fixed maturity portfolio) at December 31, 2023 and December 31, 2022, respectively. Additionally, the Company has exposure to real estate investment trusts with an average rating of BBB+, which had a fair value of $ 425 million ( 2 % of the total fixed maturity portfolio) and $ 428 million ( 3 % of the total fixed maturity portfolio) at December 31, 2023 and December 31, 2022, respectively. | text | 428 | monetaryItemType | text: <entity> 428 </entity> <entity type> monetaryItemType </entity type> <context> The Company has exposure to banks within our fixed maturity portfolio, with an average credit rating of A- . The Company’s bank securities had a fair value of $ 1.3 billion ( 7 % of the total fixed maturity portfolio) and $ 1.3 billion ( 8 % of the total fixed maturity portfolio) at December 31, 2023 and December 31, 2022, respectively. Additionally, the Company has exposure to real estate investment trusts with an average rating of BBB+, which had a fair value of $ 425 million ( 2 % of the total fixed maturity portfolio) and $ 428 million ( 3 % of the total fixed maturity portfolio) at December 31, 2023 and December 31, 2022, respectively. </context> | us-gaap:AvailableForSaleSecuritiesDebtSecurities |
For the years ended 2023, 2022 and 2021, the investment funds, accounted for under the fair value option method, recorded $ 52.3 million, $ 40.3 million, and $ 26.7 million, respectively, in net investment income. Refer to | text | 52.3 | monetaryItemType | text: <entity> 52.3 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended 2023, 2022 and 2021, the investment funds, accounted for under the fair value option method, recorded $ 52.3 million, $ 40.3 million, and $ 26.7 million, respectively, in net investment income. Refer to </context> | us-gaap:NetInvestmentIncome |
For the years ended 2023, 2022 and 2021, the investment funds, accounted for under the fair value option method, recorded $ 52.3 million, $ 40.3 million, and $ 26.7 million, respectively, in net investment income. Refer to | text | 40.3 | monetaryItemType | text: <entity> 40.3 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended 2023, 2022 and 2021, the investment funds, accounted for under the fair value option method, recorded $ 52.3 million, $ 40.3 million, and $ 26.7 million, respectively, in net investment income. Refer to </context> | us-gaap:NetInvestmentIncome |
For the years ended 2023, 2022 and 2021, the investment funds, accounted for under the fair value option method, recorded $ 52.3 million, $ 40.3 million, and $ 26.7 million, respectively, in net investment income. Refer to | text | 26.7 | monetaryItemType | text: <entity> 26.7 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended 2023, 2022 and 2021, the investment funds, accounted for under the fair value option method, recorded $ 52.3 million, $ 40.3 million, and $ 26.7 million, respectively, in net investment income. Refer to </context> | us-gaap:NetInvestmentIncome |
Gross unrealized losses decreased from $ 2.04 billion at December 31, 2022 to $ 1.50 billion at December 31, 2023, a decrease of $ 538 million. The decrease in the gross unrealized losses from the prior year was primarily attributable to the decrease in market interest rates. | text | 2.04 | monetaryItemType | text: <entity> 2.04 </entity> <entity type> monetaryItemType </entity type> <context> Gross unrealized losses decreased from $ 2.04 billion at December 31, 2022 to $ 1.50 billion at December 31, 2023, a decrease of $ 538 million. The decrease in the gross unrealized losses from the prior year was primarily attributable to the decrease in market interest rates. </context> | us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss |
Gross unrealized losses decreased from $ 2.04 billion at December 31, 2022 to $ 1.50 billion at December 31, 2023, a decrease of $ 538 million. The decrease in the gross unrealized losses from the prior year was primarily attributable to the decrease in market interest rates. | text | 1.50 | monetaryItemType | text: <entity> 1.50 </entity> <entity type> monetaryItemType </entity type> <context> Gross unrealized losses decreased from $ 2.04 billion at December 31, 2022 to $ 1.50 billion at December 31, 2023, a decrease of $ 538 million. The decrease in the gross unrealized losses from the prior year was primarily attributable to the decrease in market interest rates. </context> | us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss |
Corporate fixed maturities represent 73 % of Globe Life's invested assets. These investments are spread across a wide range of industries. Below are the ten largest industry concentrations held in the portfolio of corporate fixed maturities at December 31, 2023, based on fair value: | text | 73 | percentItemType | text: <entity> 73 </entity> <entity type> percentItemType </entity type> <context> Corporate fixed maturities represent 73 % of Globe Life's invested assets. These investments are spread across a wide range of industries. Below are the ten largest industry concentrations held in the portfolio of corporate fixed maturities at December 31, 2023, based on fair value: </context> | us-gaap:ConcentrationRiskPercentage1 |
As of December 31, 2023, the Company evaluated the commercial mortgage loan portfolio on a pool basis to determine the allowance for credit losses. At the end of the period, the Company had 28 loans in the portfolio. For the year ended December 31, 2023, the allowance for credit losses increased by $ 1.9 million to $ 3.7 million. Additionally, there was one foreclosure that resulted in a $ 2.9 million after tax realized loss during the period. The provision for credit losses is included in "Realized gains (losses)" in the | text | 1.9 | monetaryItemType | text: <entity> 1.9 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the Company evaluated the commercial mortgage loan portfolio on a pool basis to determine the allowance for credit losses. At the end of the period, the Company had 28 loans in the portfolio. For the year ended December 31, 2023, the allowance for credit losses increased by $ 1.9 million to $ 3.7 million. Additionally, there was one foreclosure that resulted in a $ 2.9 million after tax realized loss during the period. The provision for credit losses is included in "Realized gains (losses)" in the </context> | us-gaap:FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease |
As of December 31, 2023, the Company evaluated the commercial mortgage loan portfolio on a pool basis to determine the allowance for credit losses. At the end of the period, the Company had 28 loans in the portfolio. For the year ended December 31, 2023, the allowance for credit losses increased by $ 1.9 million to $ 3.7 million. Additionally, there was one foreclosure that resulted in a $ 2.9 million after tax realized loss during the period. The provision for credit losses is included in "Realized gains (losses)" in the | text | 3.7 | monetaryItemType | text: <entity> 3.7 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the Company evaluated the commercial mortgage loan portfolio on a pool basis to determine the allowance for credit losses. At the end of the period, the Company had 28 loans in the portfolio. For the year ended December 31, 2023, the allowance for credit losses increased by $ 1.9 million to $ 3.7 million. Additionally, there was one foreclosure that resulted in a $ 2.9 million after tax realized loss during the period. The provision for credit losses is included in "Realized gains (losses)" in the </context> | us-gaap:FinancingReceivableAllowanceForCreditLosses |
As of December 31, 2023, the Company evaluated the commercial mortgage loan portfolio on a pool basis to determine the allowance for credit losses. At the end of the period, the Company had 28 loans in the portfolio. For the year ended December 31, 2023, the allowance for credit losses increased by $ 1.9 million to $ 3.7 million. Additionally, there was one foreclosure that resulted in a $ 2.9 million after tax realized loss during the period. The provision for credit losses is included in "Realized gains (losses)" in the | text | 2.9 | monetaryItemType | text: <entity> 2.9 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the Company evaluated the commercial mortgage loan portfolio on a pool basis to determine the allowance for credit losses. At the end of the period, the Company had 28 loans in the portfolio. For the year ended December 31, 2023, the allowance for credit losses increased by $ 1.9 million to $ 3.7 million. Additionally, there was one foreclosure that resulted in a $ 2.9 million after tax realized loss during the period. The provision for credit losses is included in "Realized gains (losses)" in the </context> | us-gaap:RealizedInvestmentGainsLosses |
There were no delinquent commercial mortgage loans as of December 31, 2023 and December 31, 2022. As of December 31, 2023 and December 31, 2022, the Company had no commercial mortgage loans in non-accrual status. The Company's unfunded commitment balance to commercial loan borrowers was $ 25 million as of December 31, 2023. | text | 25 | monetaryItemType | text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> There were no delinquent commercial mortgage loans as of December 31, 2023 and December 31, 2022. As of December 31, 2023 and December 31, 2022, the Company had no commercial mortgage loans in non-accrual status. The Company's unfunded commitment balance to commercial loan borrowers was $ 25 million as of December 31, 2023. </context> | us-gaap:NotesReceivableNet |
Insurance affiliates also assume insurance risks of other external companies. Life reinsurance assumed represented 0.9 % and 1.0 % of life insurance in force at December 31, 2023 and 2022, respectively, and reinsurance assumed on life and accident and health products represented 1.3 % and 1.5 % of premium income for 2023 and 2022, respectively. | text | 0.9 | percentItemType | text: <entity> 0.9 </entity> <entity type> percentItemType </entity type> <context> Insurance affiliates also assume insurance risks of other external companies. Life reinsurance assumed represented 0.9 % and 1.0 % of life insurance in force at December 31, 2023 and 2022, respectively, and reinsurance assumed on life and accident and health products represented 1.3 % and 1.5 % of premium income for 2023 and 2022, respectively. </context> | us-gaap:LifeInsuranceAssumedRatio |
Insurance affiliates also assume insurance risks of other external companies. Life reinsurance assumed represented 0.9 % and 1.0 % of life insurance in force at December 31, 2023 and 2022, respectively, and reinsurance assumed on life and accident and health products represented 1.3 % and 1.5 % of premium income for 2023 and 2022, respectively. | text | 1.0 | percentItemType | text: <entity> 1.0 </entity> <entity type> percentItemType </entity type> <context> Insurance affiliates also assume insurance risks of other external companies. Life reinsurance assumed represented 0.9 % and 1.0 % of life insurance in force at December 31, 2023 and 2022, respectively, and reinsurance assumed on life and accident and health products represented 1.3 % and 1.5 % of premium income for 2023 and 2022, respectively. </context> | us-gaap:LifeInsuranceAssumedRatio |
Insurance affiliates also assume insurance risks of other external companies. Life reinsurance assumed represented 0.9 % and 1.0 % of life insurance in force at December 31, 2023 and 2022, respectively, and reinsurance assumed on life and accident and health products represented 1.3 % and 1.5 % of premium income for 2023 and 2022, respectively. | text | 1.3 | percentItemType | text: <entity> 1.3 </entity> <entity type> percentItemType </entity type> <context> Insurance affiliates also assume insurance risks of other external companies. Life reinsurance assumed represented 0.9 % and 1.0 % of life insurance in force at December 31, 2023 and 2022, respectively, and reinsurance assumed on life and accident and health products represented 1.3 % and 1.5 % of premium income for 2023 and 2022, respectively. </context> | us-gaap:PremiumsPercentageAssumedToNet |
Insurance affiliates also assume insurance risks of other external companies. Life reinsurance assumed represented 0.9 % and 1.0 % of life insurance in force at December 31, 2023 and 2022, respectively, and reinsurance assumed on life and accident and health products represented 1.3 % and 1.5 % of premium income for 2023 and 2022, respectively. | text | 1.5 | percentItemType | text: <entity> 1.5 </entity> <entity type> percentItemType </entity type> <context> Insurance affiliates also assume insurance risks of other external companies. Life reinsurance assumed represented 0.9 % and 1.0 % of life insurance in force at December 31, 2023 and 2022, respectively, and reinsurance assumed on life and accident and health products represented 1.3 % and 1.5 % of premium income for 2023 and 2022, respectively. </context> | us-gaap:PremiumsPercentageAssumedToNet |
At December 31, 2023, Globe Life had in place three guarantee agreements which were either Parent Company guarantees of subsidiary obligations to a third party or Parent Company guarantees of obligations between wholly-owned subsidiaries. As of December 31, 2023, Globe Life had no liability with respect to these guarantees. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, Globe Life had in place three guarantee agreements which were either Parent Company guarantees of subsidiary obligations to a third party or Parent Company guarantees of obligations between wholly-owned subsidiaries. As of December 31, 2023, Globe Life had no liability with respect to these guarantees. </context> | us-gaap:GuarantyLiabilities |
The maximum amount of letters of credit available is $ 250 million. The Parent Company would be liable to the extent that TMK Re, Ltd. does not pay the reinsured party. On March 29, 2023, the letters of credit were amended to reduce the current amount outstanding to $ 115 million from $ 125 million outstanding. | text | 115 | monetaryItemType | text: <entity> 115 </entity> <entity type> monetaryItemType </entity type> <context> The maximum amount of letters of credit available is $ 250 million. The Parent Company would be liable to the extent that TMK Re, Ltd. does not pay the reinsured party. On March 29, 2023, the letters of credit were amended to reduce the current amount outstanding to $ 115 million from $ 125 million outstanding. </context> | us-gaap:LettersOfCreditOutstandingAmount |
The maximum amount of letters of credit available is $ 250 million. The Parent Company would be liable to the extent that TMK Re, Ltd. does not pay the reinsured party. On March 29, 2023, the letters of credit were amended to reduce the current amount outstanding to $ 115 million from $ 125 million outstanding. | text | 125 | monetaryItemType | text: <entity> 125 </entity> <entity type> monetaryItemType </entity type> <context> The maximum amount of letters of credit available is $ 250 million. The Parent Company would be liable to the extent that TMK Re, Ltd. does not pay the reinsured party. On March 29, 2023, the letters of credit were amended to reduce the current amount outstanding to $ 115 million from $ 125 million outstanding. </context> | us-gaap:LettersOfCreditOutstandingAmount |
Equipment leases: Globe Life has guaranteed performance of certain of its subsidiaries as lessees under two aviation leasing arrangements. At December 31, 2023, total remaining undiscounted payments under the leases were approximately $ 1 million. The Parent Company would be responsible for any subsidiary obligation in the event the subsidiary did not make payments or otherwise perform under the terms of the lease. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> Equipment leases: Globe Life has guaranteed performance of certain of its subsidiaries as lessees under two aviation leasing arrangements. At December 31, 2023, total remaining undiscounted payments under the leases were approximately $ 1 million. The Parent Company would be responsible for any subsidiary obligation in the event the subsidiary did not make payments or otherwise perform under the terms of the lease. </context> | us-gaap:GuaranteeObligationsMaximumExposure |
As of December 31, 2023 for the life segment using current discount rates, the Company anticipates $ 28.9 billion of expected future gross premiums and $ 12.3 billion of expected future net premiums. As of December 31, 2022 and December 31, 2021 using current discount rates, the Company anticipated $ 27.1 billion and $ 32.9 billion of expected future gross premiums and $ 11.7 billion and $ 14.1 billion in expected future net premiums, respectively. For each respective period, only expected future net premiums are included in the determination of the liability for future policy benefits on the balance sheet, while the difference between the expected future gross premiums and the expected future net premiums is not. | text | 12.3 | monetaryItemType | text: <entity> 12.3 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023 for the life segment using current discount rates, the Company anticipates $ 28.9 billion of expected future gross premiums and $ 12.3 billion of expected future net premiums. As of December 31, 2022 and December 31, 2021 using current discount rates, the Company anticipated $ 27.1 billion and $ 32.9 billion of expected future gross premiums and $ 11.7 billion and $ 14.1 billion in expected future net premiums, respectively. For each respective period, only expected future net premiums are included in the determination of the liability for future policy benefits on the balance sheet, while the difference between the expected future gross premiums and the expected future net premiums is not. </context> | us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange |
As of December 31, 2023 for the life segment using current discount rates, the Company anticipates $ 28.9 billion of expected future gross premiums and $ 12.3 billion of expected future net premiums. As of December 31, 2022 and December 31, 2021 using current discount rates, the Company anticipated $ 27.1 billion and $ 32.9 billion of expected future gross premiums and $ 11.7 billion and $ 14.1 billion in expected future net premiums, respectively. For each respective period, only expected future net premiums are included in the determination of the liability for future policy benefits on the balance sheet, while the difference between the expected future gross premiums and the expected future net premiums is not. | text | 11.7 | monetaryItemType | text: <entity> 11.7 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023 for the life segment using current discount rates, the Company anticipates $ 28.9 billion of expected future gross premiums and $ 12.3 billion of expected future net premiums. As of December 31, 2022 and December 31, 2021 using current discount rates, the Company anticipated $ 27.1 billion and $ 32.9 billion of expected future gross premiums and $ 11.7 billion and $ 14.1 billion in expected future net premiums, respectively. For each respective period, only expected future net premiums are included in the determination of the liability for future policy benefits on the balance sheet, while the difference between the expected future gross premiums and the expected future net premiums is not. </context> | us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange |
As of December 31, 2023 for the life segment using current discount rates, the Company anticipates $ 28.9 billion of expected future gross premiums and $ 12.3 billion of expected future net premiums. As of December 31, 2022 and December 31, 2021 using current discount rates, the Company anticipated $ 27.1 billion and $ 32.9 billion of expected future gross premiums and $ 11.7 billion and $ 14.1 billion in expected future net premiums, respectively. For each respective period, only expected future net premiums are included in the determination of the liability for future policy benefits on the balance sheet, while the difference between the expected future gross premiums and the expected future net premiums is not. | text | 14.1 | monetaryItemType | text: <entity> 14.1 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023 for the life segment using current discount rates, the Company anticipates $ 28.9 billion of expected future gross premiums and $ 12.3 billion of expected future net premiums. As of December 31, 2022 and December 31, 2021 using current discount rates, the Company anticipated $ 27.1 billion and $ 32.9 billion of expected future gross premiums and $ 11.7 billion and $ 14.1 billion in expected future net premiums, respectively. For each respective period, only expected future net premiums are included in the determination of the liability for future policy benefits on the balance sheet, while the difference between the expected future gross premiums and the expected future net premiums is not. </context> | us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange |
As of December 31, 2023 for the health segment using current discount rates, the Company anticipates $ 11.8 billion of expected future gross premiums and $ 6.1 billion of expected future net premiums. As of December 31, 2022 and December 31, 2021 using current discount rates, the Company anticipated $ 10.3 billion and $ 12.4 billion of expected future gross premiums and $ 5.2 billion and $ 6.4 billion in expected future net premiums, respectively. For each respective period, only expected future net premiums are included in the determination of the liability for future | text | 6.1 | monetaryItemType | text: <entity> 6.1 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023 for the health segment using current discount rates, the Company anticipates $ 11.8 billion of expected future gross premiums and $ 6.1 billion of expected future net premiums. As of December 31, 2022 and December 31, 2021 using current discount rates, the Company anticipated $ 10.3 billion and $ 12.4 billion of expected future gross premiums and $ 5.2 billion and $ 6.4 billion in expected future net premiums, respectively. For each respective period, only expected future net premiums are included in the determination of the liability for future </context> | us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange |
As of December 31, 2023 for the health segment using current discount rates, the Company anticipates $ 11.8 billion of expected future gross premiums and $ 6.1 billion of expected future net premiums. As of December 31, 2022 and December 31, 2021 using current discount rates, the Company anticipated $ 10.3 billion and $ 12.4 billion of expected future gross premiums and $ 5.2 billion and $ 6.4 billion in expected future net premiums, respectively. For each respective period, only expected future net premiums are included in the determination of the liability for future | text | 5.2 | monetaryItemType | text: <entity> 5.2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023 for the health segment using current discount rates, the Company anticipates $ 11.8 billion of expected future gross premiums and $ 6.1 billion of expected future net premiums. As of December 31, 2022 and December 31, 2021 using current discount rates, the Company anticipated $ 10.3 billion and $ 12.4 billion of expected future gross premiums and $ 5.2 billion and $ 6.4 billion in expected future net premiums, respectively. For each respective period, only expected future net premiums are included in the determination of the liability for future </context> | us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange |
As of December 31, 2023 for the health segment using current discount rates, the Company anticipates $ 11.8 billion of expected future gross premiums and $ 6.1 billion of expected future net premiums. As of December 31, 2022 and December 31, 2021 using current discount rates, the Company anticipated $ 10.3 billion and $ 12.4 billion of expected future gross premiums and $ 5.2 billion and $ 6.4 billion in expected future net premiums, respectively. For each respective period, only expected future net premiums are included in the determination of the liability for future | text | 6.4 | monetaryItemType | text: <entity> 6.4 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023 for the health segment using current discount rates, the Company anticipates $ 11.8 billion of expected future gross premiums and $ 6.1 billion of expected future net premiums. As of December 31, 2022 and December 31, 2021 using current discount rates, the Company anticipated $ 10.3 billion and $ 12.4 billion of expected future gross premiums and $ 5.2 billion and $ 6.4 billion in expected future net premiums, respectively. For each respective period, only expected future net premiums are included in the determination of the liability for future </context> | us-gaap:LiabilityForFuturePolicyBenefitExpectedNetPremiumBeforeReinsuranceAfterDiscountRateChange |
: Globe Life has a $ 20.1 million net operating loss (NOL) carryforward at December 31, 2023, of which $ 7.2 million was created prior to 2017 and will begin to expire in 2032 if not otherwise used to offset future taxable income. The remaining NOL carryforward of $ 12.9 million may be carried forward indefinitely. A valuation allowance is to be recorded when it is more likely than not that deferred tax assets will not be realized by the Company. No valuation allowance has been recorded relating to Globe Life's deferred tax assets as management has determined that Globe Life will more likely than not have sufficient taxable income in future periods to fully realize its existing deferred tax assets. | text | 20.1 | monetaryItemType | text: <entity> 20.1 </entity> <entity type> monetaryItemType </entity type> <context> : Globe Life has a $ 20.1 million net operating loss (NOL) carryforward at December 31, 2023, of which $ 7.2 million was created prior to 2017 and will begin to expire in 2032 if not otherwise used to offset future taxable income. The remaining NOL carryforward of $ 12.9 million may be carried forward indefinitely. A valuation allowance is to be recorded when it is more likely than not that deferred tax assets will not be realized by the Company. No valuation allowance has been recorded relating to Globe Life's deferred tax assets as management has determined that Globe Life will more likely than not have sufficient taxable income in future periods to fully realize its existing deferred tax assets. </context> | us-gaap:OperatingLossCarryforwards |
: Globe Life has a $ 20.1 million net operating loss (NOL) carryforward at December 31, 2023, of which $ 7.2 million was created prior to 2017 and will begin to expire in 2032 if not otherwise used to offset future taxable income. The remaining NOL carryforward of $ 12.9 million may be carried forward indefinitely. A valuation allowance is to be recorded when it is more likely than not that deferred tax assets will not be realized by the Company. No valuation allowance has been recorded relating to Globe Life's deferred tax assets as management has determined that Globe Life will more likely than not have sufficient taxable income in future periods to fully realize its existing deferred tax assets. | text | No | monetaryItemType | text: <entity> No </entity> <entity type> monetaryItemType </entity type> <context> : Globe Life has a $ 20.1 million net operating loss (NOL) carryforward at December 31, 2023, of which $ 7.2 million was created prior to 2017 and will begin to expire in 2032 if not otherwise used to offset future taxable income. The remaining NOL carryforward of $ 12.9 million may be carried forward indefinitely. A valuation allowance is to be recorded when it is more likely than not that deferred tax assets will not be realized by the Company. No valuation allowance has been recorded relating to Globe Life's deferred tax assets as management has determined that Globe Life will more likely than not have sufficient taxable income in future periods to fully realize its existing deferred tax assets. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
Defined benefit and SERP plan contributions were $ 24.4 million in 2023, $ 29.8 million in 2022, and $ 17.9 million in 2021. In 2024, the Company does not expect to increase contributions to the plans from what was contributed in 2023. | text | 24.4 | monetaryItemType | text: <entity> 24.4 </entity> <entity type> monetaryItemType </entity type> <context> Defined benefit and SERP plan contributions were $ 24.4 million in 2023, $ 29.8 million in 2022, and $ 17.9 million in 2021. In 2024, the Company does not expect to increase contributions to the plans from what was contributed in 2023. </context> | us-gaap:DefinedBenefitPlanContributionsByEmployer |
Defined benefit and SERP plan contributions were $ 24.4 million in 2023, $ 29.8 million in 2022, and $ 17.9 million in 2021. In 2024, the Company does not expect to increase contributions to the plans from what was contributed in 2023. | text | 29.8 | monetaryItemType | text: <entity> 29.8 </entity> <entity type> monetaryItemType </entity type> <context> Defined benefit and SERP plan contributions were $ 24.4 million in 2023, $ 29.8 million in 2022, and $ 17.9 million in 2021. In 2024, the Company does not expect to increase contributions to the plans from what was contributed in 2023. </context> | us-gaap:DefinedBenefitPlanContributionsByEmployer |
Defined benefit and SERP plan contributions were $ 24.4 million in 2023, $ 29.8 million in 2022, and $ 17.9 million in 2021. In 2024, the Company does not expect to increase contributions to the plans from what was contributed in 2023. | text | 17.9 | monetaryItemType | text: <entity> 17.9 </entity> <entity type> monetaryItemType </entity type> <context> Defined benefit and SERP plan contributions were $ 24.4 million in 2023, $ 29.8 million in 2022, and $ 17.9 million in 2021. In 2024, the Company does not expect to increase contributions to the plans from what was contributed in 2023. </context> | us-gaap:DefinedBenefitPlanContributionsByEmployer |
An additional $ 150 million par value and book value is held by insurance subsidiaries that eliminates in consolidation. | text | 150 | monetaryItemType | text: <entity> 150 </entity> <entity type> monetaryItemType </entity type> <context> An additional $ 150 million par value and book value is held by insurance subsidiaries that eliminates in consolidation. </context> | us-gaap:LongTermDebt |
Interest calculated quarterly using Secured Overnight Financing Rate (SOFR) plus 135 basis points. | text | 135 | percentItemType | text: <entity> 135 </entity> <entity type> percentItemType </entity type> <context> Interest calculated quarterly using Secured Overnight Financing Rate (SOFR) plus 135 basis points. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
The $ 166 million of 7.875 % Senior notes matured on May 15, 2023. | text | 166 | monetaryItemType | text: <entity> 166 </entity> <entity type> monetaryItemType </entity type> <context> The $ 166 million of 7.875 % Senior notes matured on May 15, 2023. </context> | us-gaap:RepaymentsOfNotesPayable |
The $ 166 million of 7.875 % Senior notes matured on May 15, 2023. | text | 7.875 | percentItemType | text: <entity> 7.875 </entity> <entity type> percentItemType </entity type> <context> The $ 166 million of 7.875 % Senior notes matured on May 15, 2023. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The commercial paper has the highest priority of all unsecured debt, followed by senior notes then junior subordinated debentures. The senior notes are callable under a make-whole provision, and the junior subordinated debentures are subject to an optional redemption five years from issuance. Interest on the 4.25 % junior subordinated debentures is payable quarterly while all other long-term debt is payable semi-annually. | text | 4.25 | percentItemType | text: <entity> 4.25 </entity> <entity type> percentItemType </entity type> <context> The commercial paper has the highest priority of all unsecured debt, followed by senior notes then junior subordinated debentures. The senior notes are callable under a make-whole provision, and the junior subordinated debentures are subject to an optional redemption five years from issuance. Interest on the 4.25 % junior subordinated debentures is payable quarterly while all other long-term debt is payable semi-annually. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
On September 30, 2021, Globe Life amended the credit agreement dated August 24, 2020, which provides for a $ 750 million revolving credit facility that may be increased to $ 1 billion upon approval of the participating banks. The amended credit facility matures September 30, 2026, and may be extended up to two one-year periods upon the Company's request. Pursuant to this agreement, the participating lenders have agreed to make revolving loans to Globe Life and to issue secured or unsecured letters of credit. The Company has not drawn on any of the credit to date. The facility is further designated as a back-up credit line for a commercial paper program under which the Company may either borrow from the credit line or issue commercial paper at any time, with total commercial paper outstanding not to exceed the facility maximum of $ 750 million, less any letters of credit issued. Interest is charged at variable rates. In accordance with the agreement, Globe Life is subject to certain covenants regarding capitalization. As of December 31, 2023, the Company was in full compliance with these covenants. | text | 750 | monetaryItemType | text: <entity> 750 </entity> <entity type> monetaryItemType </entity type> <context> On September 30, 2021, Globe Life amended the credit agreement dated August 24, 2020, which provides for a $ 750 million revolving credit facility that may be increased to $ 1 billion upon approval of the participating banks. The amended credit facility matures September 30, 2026, and may be extended up to two one-year periods upon the Company's request. Pursuant to this agreement, the participating lenders have agreed to make revolving loans to Globe Life and to issue secured or unsecured letters of credit. The Company has not drawn on any of the credit to date. The facility is further designated as a back-up credit line for a commercial paper program under which the Company may either borrow from the credit line or issue commercial paper at any time, with total commercial paper outstanding not to exceed the facility maximum of $ 750 million, less any letters of credit issued. Interest is charged at variable rates. In accordance with the agreement, Globe Life is subject to certain covenants regarding capitalization. As of December 31, 2023, the Company was in full compliance with these covenants. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
Globe Life owned $ 22.3 million in FHLB common stock as of December 31, 2023 and $ 14.3 million as of December 31, 2022. The FHLB stock is restricted for the duration of the membership and recorded at cost (par) as required by applicable guidance. The FHLB stock is included in "Other long-term investments | text | 22.3 | monetaryItemType | text: <entity> 22.3 </entity> <entity type> monetaryItemType </entity type> <context> Globe Life owned $ 22.3 million in FHLB common stock as of December 31, 2023 and $ 14.3 million as of December 31, 2022. The FHLB stock is restricted for the duration of the membership and recorded at cost (par) as required by applicable guidance. The FHLB stock is included in "Other long-term investments </context> | us-gaap:FederalHomeLoanBankStockAndFederalReserveBankStock |
Globe Life owned $ 22.3 million in FHLB common stock as of December 31, 2023 and $ 14.3 million as of December 31, 2022. The FHLB stock is restricted for the duration of the membership and recorded at cost (par) as required by applicable guidance. The FHLB stock is included in "Other long-term investments | text | 14.3 | monetaryItemType | text: <entity> 14.3 </entity> <entity type> monetaryItemType </entity type> <context> Globe Life owned $ 22.3 million in FHLB common stock as of December 31, 2023 and $ 14.3 million as of December 31, 2022. The FHLB stock is restricted for the duration of the membership and recorded at cost (par) as required by applicable guidance. The FHLB stock is included in "Other long-term investments </context> | us-gaap:FederalHomeLoanBankStockAndFederalReserveBankStock |
Borrowings with the FHLB are subject to the availability of pledged assets at Globe Life. As of December 31, 2023, Globe Life's maximum borrowing capacity under the FHLB facility was approximately $ 1.0 billion, net of outstanding funding agreements and short-term borrowings, on pledged assets with a fair value of $ 1.3 billion. As of December 31, 2023, $ 138 million in funding agreements were outstanding with the FHLB, compared to $ 23 million as of December 31, 2022. This amount is included in "Other policyholders' funds" in the | text | 1.0 | monetaryItemType | text: <entity> 1.0 </entity> <entity type> monetaryItemType </entity type> <context> Borrowings with the FHLB are subject to the availability of pledged assets at Globe Life. As of December 31, 2023, Globe Life's maximum borrowing capacity under the FHLB facility was approximately $ 1.0 billion, net of outstanding funding agreements and short-term borrowings, on pledged assets with a fair value of $ 1.3 billion. As of December 31, 2023, $ 138 million in funding agreements were outstanding with the FHLB, compared to $ 23 million as of December 31, 2022. This amount is included in "Other policyholders' funds" in the </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
Borrowings with the FHLB are subject to the availability of pledged assets at Globe Life. As of December 31, 2023, Globe Life's maximum borrowing capacity under the FHLB facility was approximately $ 1.0 billion, net of outstanding funding agreements and short-term borrowings, on pledged assets with a fair value of $ 1.3 billion. As of December 31, 2023, $ 138 million in funding agreements were outstanding with the FHLB, compared to $ 23 million as of December 31, 2022. This amount is included in "Other policyholders' funds" in the | text | 1.3 | monetaryItemType | text: <entity> 1.3 </entity> <entity type> monetaryItemType </entity type> <context> Borrowings with the FHLB are subject to the availability of pledged assets at Globe Life. As of December 31, 2023, Globe Life's maximum borrowing capacity under the FHLB facility was approximately $ 1.0 billion, net of outstanding funding agreements and short-term borrowings, on pledged assets with a fair value of $ 1.3 billion. As of December 31, 2023, $ 138 million in funding agreements were outstanding with the FHLB, compared to $ 23 million as of December 31, 2022. This amount is included in "Other policyholders' funds" in the </context> | us-gaap:LoansReceivableFairValueDisclosure |
Borrowings with the FHLB are subject to the availability of pledged assets at Globe Life. As of December 31, 2023, Globe Life's maximum borrowing capacity under the FHLB facility was approximately $ 1.0 billion, net of outstanding funding agreements and short-term borrowings, on pledged assets with a fair value of $ 1.3 billion. As of December 31, 2023, $ 138 million in funding agreements were outstanding with the FHLB, compared to $ 23 million as of December 31, 2022. This amount is included in "Other policyholders' funds" in the | text | 138 | monetaryItemType | text: <entity> 138 </entity> <entity type> monetaryItemType </entity type> <context> Borrowings with the FHLB are subject to the availability of pledged assets at Globe Life. As of December 31, 2023, Globe Life's maximum borrowing capacity under the FHLB facility was approximately $ 1.0 billion, net of outstanding funding agreements and short-term borrowings, on pledged assets with a fair value of $ 1.3 billion. As of December 31, 2023, $ 138 million in funding agreements were outstanding with the FHLB, compared to $ 23 million as of December 31, 2022. This amount is included in "Other policyholders' funds" in the </context> | us-gaap:LineOfCredit |
Borrowings with the FHLB are subject to the availability of pledged assets at Globe Life. As of December 31, 2023, Globe Life's maximum borrowing capacity under the FHLB facility was approximately $ 1.0 billion, net of outstanding funding agreements and short-term borrowings, on pledged assets with a fair value of $ 1.3 billion. As of December 31, 2023, $ 138 million in funding agreements were outstanding with the FHLB, compared to $ 23 million as of December 31, 2022. This amount is included in "Other policyholders' funds" in the | text | 23 | monetaryItemType | text: <entity> 23 </entity> <entity type> monetaryItemType </entity type> <context> Borrowings with the FHLB are subject to the availability of pledged assets at Globe Life. As of December 31, 2023, Globe Life's maximum borrowing capacity under the FHLB facility was approximately $ 1.0 billion, net of outstanding funding agreements and short-term borrowings, on pledged assets with a fair value of $ 1.3 billion. As of December 31, 2023, $ 138 million in funding agreements were outstanding with the FHLB, compared to $ 23 million as of December 31, 2022. This amount is included in "Other policyholders' funds" in the </context> | us-gaap:LineOfCredit |
For the 2022 and 2023 performance share grants, actual shares that could be distributed range from 0 to 220 thousand for the 2022 grants and 0 to 122 thousand shares for the 2023 grants. | text | 0 | sharesItemType | text: <entity> 0 </entity> <entity type> sharesItemType </entity type> <context> For the 2022 and 2023 performance share grants, actual shares that could be distributed range from 0 to 220 thousand for the 2022 grants and 0 to 122 thousand shares for the 2023 grants. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
For the 2022 and 2023 performance share grants, actual shares that could be distributed range from 0 to 220 thousand for the 2022 grants and 0 to 122 thousand shares for the 2023 grants. | text | 220 | sharesItemType | text: <entity> 220 </entity> <entity type> sharesItemType </entity type> <context> For the 2022 and 2023 performance share grants, actual shares that could be distributed range from 0 to 220 thousand for the 2022 grants and 0 to 122 thousand shares for the 2023 grants. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
For the 2022 and 2023 performance share grants, actual shares that could be distributed range from 0 to 220 thousand for the 2022 grants and 0 to 122 thousand shares for the 2023 grants. | text | 122 | sharesItemType | text: <entity> 122 </entity> <entity type> sharesItemType </entity type> <context> For the 2022 and 2023 performance share grants, actual shares that could be distributed range from 0 to 220 thousand for the 2022 grants and 0 to 122 thousand shares for the 2023 grants. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
Globe Life is organized into four segments: life insurance, supplemental health insurance, annuities, and investments. In addition, other expenses not included in these segments are reported in "Corporate & Other." | text | four | integerItemType | text: <entity> four </entity> <entity type> integerItemType </entity type> <context> Globe Life is organized into four segments: life insurance, supplemental health insurance, annuities, and investments. In addition, other expenses not included in these segments are reported in "Corporate & Other." </context> | us-gaap:NumberOfOperatingSegments |
As of December 31, 2023, Globe Life had 351 thousand shares of Cumulative Preferred Stock, Series A, issued and outstanding, of which 280 thousand shares were 6.50 % Cumulative Preferred Stock, Series A, and 71 thousand shares were 7.15 % Cumulative Preferred Stock, Series A (collectively, the “Series A Preferred Stock”). All issued and outstanding shares of Series A Preferred Stock were held by wholly-owned insurance subsidiaries. In the event of liquidation, the holders of the Series A Preferred Stock at the time outstanding would be entitled to receive a liquidating distribution out of the assets legally available to stockholders in the amount of $ 1 thousand per share or $ 351 million in the aggregate, plus any accrued and unpaid dividends, before any distribution is made to holders of Globe Life common stock. Holders of Series A Preferred Stock do not have any voting rights nor have rights to convert such shares into shares of any other class of Globe Life capital stock. | text | 6.50 | percentItemType | text: <entity> 6.50 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2023, Globe Life had 351 thousand shares of Cumulative Preferred Stock, Series A, issued and outstanding, of which 280 thousand shares were 6.50 % Cumulative Preferred Stock, Series A, and 71 thousand shares were 7.15 % Cumulative Preferred Stock, Series A (collectively, the “Series A Preferred Stock”). All issued and outstanding shares of Series A Preferred Stock were held by wholly-owned insurance subsidiaries. In the event of liquidation, the holders of the Series A Preferred Stock at the time outstanding would be entitled to receive a liquidating distribution out of the assets legally available to stockholders in the amount of $ 1 thousand per share or $ 351 million in the aggregate, plus any accrued and unpaid dividends, before any distribution is made to holders of Globe Life common stock. Holders of Series A Preferred Stock do not have any voting rights nor have rights to convert such shares into shares of any other class of Globe Life capital stock. </context> | us-gaap:PreferredStockDividendRatePercentage |
As of December 31, 2023, Globe Life had 351 thousand shares of Cumulative Preferred Stock, Series A, issued and outstanding, of which 280 thousand shares were 6.50 % Cumulative Preferred Stock, Series A, and 71 thousand shares were 7.15 % Cumulative Preferred Stock, Series A (collectively, the “Series A Preferred Stock”). All issued and outstanding shares of Series A Preferred Stock were held by wholly-owned insurance subsidiaries. In the event of liquidation, the holders of the Series A Preferred Stock at the time outstanding would be entitled to receive a liquidating distribution out of the assets legally available to stockholders in the amount of $ 1 thousand per share or $ 351 million in the aggregate, plus any accrued and unpaid dividends, before any distribution is made to holders of Globe Life common stock. Holders of Series A Preferred Stock do not have any voting rights nor have rights to convert such shares into shares of any other class of Globe Life capital stock. | text | 7.15 | percentItemType | text: <entity> 7.15 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2023, Globe Life had 351 thousand shares of Cumulative Preferred Stock, Series A, issued and outstanding, of which 280 thousand shares were 6.50 % Cumulative Preferred Stock, Series A, and 71 thousand shares were 7.15 % Cumulative Preferred Stock, Series A (collectively, the “Series A Preferred Stock”). All issued and outstanding shares of Series A Preferred Stock were held by wholly-owned insurance subsidiaries. In the event of liquidation, the holders of the Series A Preferred Stock at the time outstanding would be entitled to receive a liquidating distribution out of the assets legally available to stockholders in the amount of $ 1 thousand per share or $ 351 million in the aggregate, plus any accrued and unpaid dividends, before any distribution is made to holders of Globe Life common stock. Holders of Series A Preferred Stock do not have any voting rights nor have rights to convert such shares into shares of any other class of Globe Life capital stock. </context> | us-gaap:PreferredStockDividendRatePercentage |
As of December 31, 2023, Globe Life had 351 thousand shares of Cumulative Preferred Stock, Series A, issued and outstanding, of which 280 thousand shares were 6.50 % Cumulative Preferred Stock, Series A, and 71 thousand shares were 7.15 % Cumulative Preferred Stock, Series A (collectively, the “Series A Preferred Stock”). All issued and outstanding shares of Series A Preferred Stock were held by wholly-owned insurance subsidiaries. In the event of liquidation, the holders of the Series A Preferred Stock at the time outstanding would be entitled to receive a liquidating distribution out of the assets legally available to stockholders in the amount of $ 1 thousand per share or $ 351 million in the aggregate, plus any accrued and unpaid dividends, before any distribution is made to holders of Globe Life common stock. Holders of Series A Preferred Stock do not have any voting rights nor have rights to convert such shares into shares of any other class of Globe Life capital stock. | text | 1 | perShareItemType | text: <entity> 1 </entity> <entity type> perShareItemType </entity type> <context> As of December 31, 2023, Globe Life had 351 thousand shares of Cumulative Preferred Stock, Series A, issued and outstanding, of which 280 thousand shares were 6.50 % Cumulative Preferred Stock, Series A, and 71 thousand shares were 7.15 % Cumulative Preferred Stock, Series A (collectively, the “Series A Preferred Stock”). All issued and outstanding shares of Series A Preferred Stock were held by wholly-owned insurance subsidiaries. In the event of liquidation, the holders of the Series A Preferred Stock at the time outstanding would be entitled to receive a liquidating distribution out of the assets legally available to stockholders in the amount of $ 1 thousand per share or $ 351 million in the aggregate, plus any accrued and unpaid dividends, before any distribution is made to holders of Globe Life common stock. Holders of Series A Preferred Stock do not have any voting rights nor have rights to convert such shares into shares of any other class of Globe Life capital stock. </context> | us-gaap:PreferredStockRedemptionPricePerShare |
As of December 31, 2023, Globe Life had 351 thousand shares of Cumulative Preferred Stock, Series A, issued and outstanding, of which 280 thousand shares were 6.50 % Cumulative Preferred Stock, Series A, and 71 thousand shares were 7.15 % Cumulative Preferred Stock, Series A (collectively, the “Series A Preferred Stock”). All issued and outstanding shares of Series A Preferred Stock were held by wholly-owned insurance subsidiaries. In the event of liquidation, the holders of the Series A Preferred Stock at the time outstanding would be entitled to receive a liquidating distribution out of the assets legally available to stockholders in the amount of $ 1 thousand per share or $ 351 million in the aggregate, plus any accrued and unpaid dividends, before any distribution is made to holders of Globe Life common stock. Holders of Series A Preferred Stock do not have any voting rights nor have rights to convert such shares into shares of any other class of Globe Life capital stock. | text | 351 | monetaryItemType | text: <entity> 351 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, Globe Life had 351 thousand shares of Cumulative Preferred Stock, Series A, issued and outstanding, of which 280 thousand shares were 6.50 % Cumulative Preferred Stock, Series A, and 71 thousand shares were 7.15 % Cumulative Preferred Stock, Series A (collectively, the “Series A Preferred Stock”). All issued and outstanding shares of Series A Preferred Stock were held by wholly-owned insurance subsidiaries. In the event of liquidation, the holders of the Series A Preferred Stock at the time outstanding would be entitled to receive a liquidating distribution out of the assets legally available to stockholders in the amount of $ 1 thousand per share or $ 351 million in the aggregate, plus any accrued and unpaid dividends, before any distribution is made to holders of Globe Life common stock. Holders of Series A Preferred Stock do not have any voting rights nor have rights to convert such shares into shares of any other class of Globe Life capital stock. </context> | us-gaap:PreferredStockRedemptionAmount |
Excludes policy charges of $ 12.9 million, $ 13.5 million, and $ 14.2 million in each of the years 2023, 2022, and 2021, respectively. | text | 12.9 | monetaryItemType | text: <entity> 12.9 </entity> <entity type> monetaryItemType </entity type> <context> Excludes policy charges of $ 12.9 million, $ 13.5 million, and $ 14.2 million in each of the years 2023, 2022, and 2021, respectively. </context> | us-gaap:InsuranceCommissionsAndFees |
Excludes policy charges of $ 12.9 million, $ 13.5 million, and $ 14.2 million in each of the years 2023, 2022, and 2021, respectively. | text | 13.5 | monetaryItemType | text: <entity> 13.5 </entity> <entity type> monetaryItemType </entity type> <context> Excludes policy charges of $ 12.9 million, $ 13.5 million, and $ 14.2 million in each of the years 2023, 2022, and 2021, respectively. </context> | us-gaap:InsuranceCommissionsAndFees |
Excludes policy charges of $ 12.9 million, $ 13.5 million, and $ 14.2 million in each of the years 2023, 2022, and 2021, respectively. | text | 14.2 | monetaryItemType | text: <entity> 14.2 </entity> <entity type> monetaryItemType </entity type> <context> Excludes policy charges of $ 12.9 million, $ 13.5 million, and $ 14.2 million in each of the years 2023, 2022, and 2021, respectively. </context> | us-gaap:InsuranceCommissionsAndFees |
Depreciation expense is computed principally using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of depreciable assets are as follows: buildings and land improvements, 20 to 40 years, computer hardware and software, three to six years , and machinery and equipment, three to 25 years. Depreciation expense was $ 118 million in 2024, $ 115 million in 2023 and $ 112 million in 2022. | text | 118 | monetaryItemType | text: <entity> 118 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense is computed principally using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of depreciable assets are as follows: buildings and land improvements, 20 to 40 years, computer hardware and software, three to six years , and machinery and equipment, three to 25 years. Depreciation expense was $ 118 million in 2024, $ 115 million in 2023 and $ 112 million in 2022. </context> | us-gaap:Depreciation |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.